• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食补充剂在糖尿病管理中的应用:潜在风险与益处

Dietary supplements in the management of diabetes: potential risks and benefits.

作者信息

Geil Patti, Shane-McWhorter Laura

机构信息

Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA.

出版信息

J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S59-65. doi: 10.1016/j.jada.2008.01.020.

DOI:10.1016/j.jada.2008.01.020
PMID:18358258
Abstract

A wide range of products claiming to lower blood glucose levels or prevent and treat diabetes complications and comorbidities are marketed to the public. Yet many individuals with diabetes are reluctant to inform their health care providers of complementary therapy use. As the nutrition experts on diabetes care teams, registered dietitians, in conjunction with pharmacists, are uniquely positioned to encourage patients to communicate openly about their use of dietary supplements, provide safety and efficacy information about supplements, and discourage use of dangerous or ineffective products. Areas of concern with dietary supplement use include potential side effects, drug interactions, and lack of product standardization, in addition to the increased costs that patients may incur when they use ineffective therapies or delay treatment with proven therapeutic agents. The science behind dietary supplements is evolving and registered dietitians must fully understand the potential risks and benefits to advise their patients appropriately, yet respect their health care values and beliefs.

摘要

各种各样声称能降低血糖水平或预防和治疗糖尿病并发症及合并症的产品在向公众销售。然而,许多糖尿病患者不愿告知其医疗服务提供者他们使用补充疗法的情况。作为糖尿病护理团队中的营养专家,注册营养师与药剂师一道,在鼓励患者就其使用膳食补充剂的情况进行坦诚交流、提供有关补充剂的安全性和有效性信息以及劝阻使用危险或无效产品方面具有独特的地位。使用膳食补充剂令人担忧的方面包括潜在的副作用、药物相互作用以及缺乏产品标准化,此外还包括患者使用无效疗法或延迟使用经证实的治疗药物时可能产生的费用增加。膳食补充剂背后的科学在不断发展,注册营养师必须充分了解其潜在风险和益处,以便适当地为患者提供建议,同时尊重他们的医疗保健价值观和信念。

相似文献

1
Dietary supplements in the management of diabetes: potential risks and benefits.膳食补充剂在糖尿病管理中的应用:潜在风险与益处
J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S59-65. doi: 10.1016/j.jada.2008.01.020.
2
Safety assurances for dietary supplements policy issues and new research paradigms.膳食补充剂的安全保障:政策问题与新研究范式
J Herb Pharmacother. 2005;5(1):3-15.
3
Dietary supplement adverse event reports: review and analysis.膳食补充剂不良事件报告:回顾与分析
Food Drug Law J. 2009;64(3):503-13.
4
Dietary supplements in weight reduction.用于减肥的膳食补充剂。
J Am Diet Assoc. 2005 May;105(5 Suppl 1):S80-6. doi: 10.1016/j.jada.2005.02.028.
5
Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health.制造商提供的关于结肠健康膳食补充剂安全性和功效声明的信息质量。
Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):578-86. doi: 10.1002/pds.1251.
6
Advising patients who use dietary supplements.为使用膳食补充剂的患者提供建议。
Am J Med. 2008 Feb;121(2):91-7. doi: 10.1016/j.amjmed.2007.10.031.
7
Risk management of nutritional supplements in chronic illness: the implications for the care of cancer and depression.
Proc Nutr Soc. 2007 Nov;66(4):483-92. doi: 10.1017/S0029665107005800.
8
New therapeutic agents for diabetes mellitus: implications for anesthetic management.
Anesth Analg. 2009 Jun;108(6):1803-10. doi: 10.1213/ane.0b013e31819dcc51.
9
Under-hyped and over-hyped drug-dietary supplement interactions and issues.被低估和被高估的药物与膳食补充剂的相互作用及问题。
Urol Nurs. 2010 Jan-Feb;30(1):85-7.
10
Physicians' understanding of the regulation of dietary supplements.医生对膳食补充剂监管的理解。
Arch Intern Med. 2007 May 14;167(9):966-9. doi: 10.1001/archinte.167.9.966.

引用本文的文献

1
Novel Therapeutic Agents for Management of Diabetes Mellitus: A Hope for Drug Designing against Diabetes Mellitus.用于糖尿病管理的新型治疗药物:糖尿病药物设计的希望
Life (Basel). 2024 Jan 8;14(1):99. doi: 10.3390/life14010099.
2
Potential Therapeutic Effects of Curcumin on Glycemic and Lipid Profile in Uncomplicated Type 2 Diabetes-A Meta-Analysis of Randomized Controlled Trial.姜黄素对单纯 2 型糖尿病患者血糖和血脂谱的潜在治疗作用:一项随机对照试验的荟萃分析。
Nutrients. 2021 Jan 27;13(2):404. doi: 10.3390/nu13020404.
3
A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS).
中草药治疗多囊卵巢综合征的临床研究综述。
Daru. 2019 Dec;27(2):863-877. doi: 10.1007/s40199-019-00312-0. Epub 2019 Nov 18.
4
Use of Food Supplements in Diabetes Mellitus Treatment in Bosnia and Herzegovina from the Pharmacists Perspective.从药剂师角度看波斯尼亚和黑塞哥维那食品补充剂在糖尿病治疗中的应用
Mater Sociomed. 2019 Jun;31(2):141-145. doi: 10.5455/msm.2019.31.141-145.
5
Preclinical Toxicological Evaluation of IDM01: The Botanical Composition of 4-Hydroxyisoleucine- and Trigonelline-based Standardized Fenugreek Seed Extract.IDM01的临床前毒理学评估:基于4-羟基异亮氨酸和胡芦巴碱的标准化胡芦巴籽提取物的植物成分
Pharmacognosy Res. 2017 Apr-Jun;9(2):138-150. doi: 10.4103/0974-8490.204649.
6
Unproven Therapies for Diabetes and Their Implications.未经证实的糖尿病治疗方法及其影响。
Adv Ther. 2017 Jan;34(1):60-77. doi: 10.1007/s12325-016-0439-x. Epub 2016 Nov 18.
7
Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.靶向胰腺β细胞治疗糖尿病的植物源化合物
Evid Based Complement Alternat Med. 2015;2015:629863. doi: 10.1155/2015/629863. Epub 2015 Oct 26.
8
Outpatient Management of Pediatric Type 1 Diabetes.儿童1型糖尿病的门诊管理
J Pediatr Pharmacol Ther. 2015 Sep-Oct;20(5):344-57. doi: 10.5863/1551-6776-20.5.344.
9
Evaluation of Fenugreek (Trigonella foenum-graceum L.), Effects Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian Syndrome.胡芦巴(Trigonella foenum-graceum L.)种子提取物对多囊卵巢综合征女性胰岛素抵抗影响的评估。
Iran J Pharm Res. 2013 Spring;12(2):475-81.
10
Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey.疾病严重程度与使用补充医学来治疗或控制 2 型糖尿病有关:来自 2002 年和 2007 年全国健康访谈调查的数据。
BMC Complement Altern Med. 2012 Oct 22;12:193. doi: 10.1186/1472-6882-12-193.